PROS1 and COVID-19: Mechanistically, phenothiazines predominantly inhibit SARS-CoV-2 pseudovirus (PsV) infection at the early stage and potentially bind to the S protein of SARS-CoV-2, which may prevent the proteolytic cleavage of the S protein, thereby exhibiting inhibitory activity against SARS-CoV-2 infection.